ATTACKPOINT DISCOVERY Trademark
Trademark Overview
On Friday, August 29, 2025, a trademark application was filed for ATTACKPOINT DISCOVERY with the United States Patent and Trademark Office. The USPTO has given the ATTACKPOINT DISCOVERY trademark a serial number of 79439112. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, December 11, 2025. This trademark is owned by Contera Pharma A/S. The ATTACKPOINT DISCOVERY trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
Research and development services in the field of pharmaceuticals and drug discovery; development of processes and methods for medical and veterinary purposes; development of preparations for medical and veterinary purposes; scientific research for medical purposes, namely, screening for the identification of drug candidates; development of precision RNA therapeutics; development of tailored RNA-based corrective interventions to target the root causes of serious diseases; research and development of new medical products for others; development and identification of novel druggable sites for pharmacological intervention using a bioinformatic discovery platform in a wet lab; screening services, bioinformatics services and modelling services to harness natural processes and modulate gene expression through platforms to generate optimized small molecules, antisense oligonucleotides (ASOs) and small interfering RNAs (siRNAs).
General Information
| Serial Number | 79439112 |
| Word Mark | ATTACKPOINT DISCOVERY |
| Filing Date | Friday, August 29, 2025 |
| Status | 630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER |
| Status Date | Thursday, December 11, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | Research and development services in the field of pharmaceuticals and drug discovery; development of processes and methods for medical and veterinary purposes; development of preparations for medical and veterinary purposes; scientific research for medical purposes, namely, screening for the identification of drug candidates; development of precision RNA therapeutics; development of tailored RNA-based corrective interventions to target the root causes of serious diseases; research and development of new medical products for others; development and identification of novel druggable sites for pharmacological intervention using a bioinformatic discovery platform in a wet lab; screening services, bioinformatics services and modelling services to harness natural processes and modulate gene expression through platforms to generate optimized small molecules, antisense oligonucleotides (ASOs) and small interfering RNAs (siRNAs). |
| Pseudo Mark | ATTACK POINT DISCOVERY |
Classification Information
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, December 11, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Contera Pharma A/S |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 65 - NOT AVAILABLE |
| Address | DK |
Trademark Events
| Event Date | Event Description |
| Thursday, December 11, 2025 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Sunday, December 14, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Sunday, December 14, 2025 | APPLICATION FILING RECEIPT MAILED |
